Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,295 papers from all fields of science
Search
Sign In
Create Free Account
Everolimus:Mass:Pt:Dose:Qn
Known as:
Everolimus Dose
, Everolimus:Kütle:Zml?:Doz:Kant
, Everoliimus:Mass:Pt:Dose:Qn
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Dosage
Drug dose (for transmitting doses for pharmacokinetics)
Mass, a measure of quantity of matter
everolimus
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Device profile of the XIENCE V and XIENCE Sierra stents for the treatment of coronary artery disease: an overview of safety and efficacy
A. Mitsis
,
M. Valgimigli
Expert Review of Medical Devices
2020
Corpus ID: 215727531
ABSTRACT Introduction: Coronary angioplasty with the use of stents transformed the percutaneous treatment of coronary artery…
Expand
2019
2019
TCT-11 Everolimus-Eluting Bioresorbable Scaffolds Versus Drug-Eluting Stents in Patients With Acute Myocardial Infarction: 2-Year Results of the Randomized ISAR-Absorb MI Trial
J. Wiebe
,
S. Schneider
,
+10 authors
R. Byrne
Journal of the American College of Cardiology
2019
Corpus ID: 204031424
2019
2019
TCTAP A-002 Evaluation of Vascular Response and Healing After Implantation of Tetrilimus Everolimus-eluting Coronary Stent by Optical Coherence Tomography (EVER-OCT): 3 and 6 Month Serial Analysis
U. Kaul
,
R. Abhaichand
,
+5 authors
Diana Yumnam
Journal of the American College of Cardiology
2019
Corpus ID: 145980510
2017
2017
Everolimus zur Therapie der fortgeschrittenen steroidresistenten chronischen Graft-versus-Host Erkrankung nach allogener hämatopoetischer Stammzelltransplantation
Anne-Marie Klink
2017
Corpus ID: 199623037
Die Behandlung der chronischen GvHD (cGvHD) stellt auch nach langjahriger Etablierung der allogenen Stammzelltransplantation eine…
Expand
2016
2016
Management of Everolimus and Voriconazole Interaction in Lung Transplant Patients
María Outeda Macías
,
P. Salvador Garrido
,
L. Elberdín Pazos
,
María Isabel Martín Herranz
Therapeutic Drug Monitoring
2016
Corpus ID: 140012052
Background: To analyze the impact of voriconazole administration on everolimus dose, trough concentrations and concentration/dose…
Expand
2016
2016
Predictors of Bioresorbable Everolimus-Eluting Scaffold Failure at Intravascular Ultrasound Examination: Asymmetry Versus Expansion.
G. Caiazzo
,
C. Di Mario
JACC: Cardiovascular Interventions
2016
Corpus ID: 36254078
Review
2015
Review
2015
Absorb bioresorbable stents for the treatment of coronary artery disease
V. Kočka
,
P. Toušek
,
P. Widimsky
Expert Review of Medical Devices
2015
Corpus ID: 207201456
Bioresorbable stents are considered to be the ‘fourth revolution’ in percutaneous coronary intervention. The first clinically…
Expand
2014
2014
Analytical Performance of QMS Everolimus Assay on Ortho Vitros 5,1 FS Fusion Analyzer: Measuring Everolimus Trough Levels for Solid Organ Transplant Recipients
Irene Shu
,
A. Wright
,
W. Chandler
,
D. Bernard
,
Ping Wang
Therapeutic Drug Monitoring
2014
Corpus ID: 1620923
Background: Everolimus has recently been approved by Food and Drug Administration for graft maintenance in liver transplant…
Expand
2014
2014
Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold
J. C. Rama-Merchán
,
A. Mattesini
,
G. Dall’Ara
,
C. Mario
Postepy w kardiologii interwencyjnej = Advances…
2014
Corpus ID: 10162539
Fully bioresorbable vascular scaffolds (BVS) are a new approach to the percutaneous treatment of coronary artery disease. The BVS…
Expand
2011
2011
AS-229 Everolimus-Eluting Versus Sirolimus-Eluting Stents in Diabetic and Nondiabetic Patients
Duk‐Woo Park
,
Chang Hoo Lee
,
+10 authors
Seung‐Jung Park
2011
Corpus ID: 71196884
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE